PDURS

News

Remepy's hybrid Parkinson's therapy poised for phase 3

Remepy's Hybridopa therapy for Parkinson's, which combines an app with levodopa therapy, has shown efficacy in a phase 2 pilot study.

News

Merck partners Remepy in PDURS-focused alliance

Merck KGaA has started working with Remepy on the development of hybrid drugs that combine medicines with digital therapeutics.

Digital

Molecules, DTx, and a breakthrough in chronic cough

Early evidence for a cough treatment digital therapeutic is compelling.

Digital

Life Sciences Industry Report 2025 pt4 cover

Life Sciences Industry Report – Digital Health

One of the most remarkable shifts in modern healthcare is how seamlessly digital platforms are becoming part of the drug development journey.

Digital

Understanding PDURS: A new era for digital health and pharma

The FDA's Prescription Drug Use-Related Software (PDURS) framework marks a significant milestone for healthcare in the US.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

PDURS explained: The FDA’s new framework for adding software...

The US FDA has recently proposed a new draft framework that enables pharma manufacturers to add software to a drug label if they can demonstrate that the software adds clinical benefit to t

Remepy's hybrid Parkinson's therapy poised for phase 3

Merck partners Remepy in PDURS-focused alliance

Molecules, DTx, and a breakthrough in chronic cough

Life Sciences Industry Report – Digital Health

Understanding PDURS: A new era for digital health and pharma

PDURS explained: The FDA’s new framework for adding software...

First trial of Bundibugyo Ebola vaccine starts in UK

Discover a new era of healthcare panel engagement: Grounded ...

PDURS

Editor's Picks